InhaleRx Limited
ASX: IRX.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Darryl Davies
- Headquarters
- Sydney, Australia
- IPO year
- 2017
- Market cap
- A$6.9M
- Website
- https://inhalerx.com.au
Loading IRX…
Loading profile data…Frequently asked questions about IRX
What does InhaleRx Limited (IRX.AX) do?
InhaleRx Limited engages in the developing and commercializing of medical drug delivery systems in Australia. It also develops inhaled drug formulations. Its solutions include Medihale inhaler, a sealed pod inhaler for use with inhaled formulations. The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in...
Where does IRX.AX trade?
InhaleRx Limited (IRX.AX) trades on the Australian Securities Exchange.
What sector is IRX.AX in?
InhaleRx Limited (IRX.AX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of InhaleRx Limited?
Darryl Davies is the chief executive officer of InhaleRx Limited (IRX.AX).
Where is InhaleRx Limited headquartered?
InhaleRx Limited is headquartered in Australia.
Does IRX.AX pay a dividend?
InhaleRx Limited (IRX.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IRX.AX go public?
InhaleRx Limited (IRX.AX) completed its initial public offering in 2017.